Overview

Radiation Therapy and Chemotherapy in Treating Patients With Hodgkin's Disease

Status:
Completed
Trial end date:
2012-01-06
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high energy x-rays to damage tumor cells. Combining more than one drug or combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy, with or without chemotherapy, with chemotherapy alone in treating patients with stage I or stage IIA Hodgkin's disease.
Phase:
Phase 3
Details
Lead Sponsor:
NCIC Clinical Trials Group
Collaborator:
Eastern Cooperative Oncology Group
Treatments:
Bleomycin
Dacarbazine
Doxorubicin
Liposomal doxorubicin
Vinblastine